The Illinois R&D Tax Credit (35 ILCS 5/201(k)): Navigating the Post-2023 ‘Written Agreement’ Requirement for Pass-Through Entity Distribution
I. Executive Summary: The Written Agreement Defined
The “Written Agreement” required for allocating the Illinois Research and Development (R&D) tax credit by a pass-through entity (PTE) is generally the entity’s governing organizational document (Partnership Operating Agreement or S Corporation Shareholder Agreement). This document must clearly dictate that tax attributes, including state tax credits, are distributed to the owners consistent with their proportionate ownership interests.
While the Illinois Income Tax Act (IITA) Section 251 grants entitlement to partners and shareholders, the Illinois Department of Revenue (IDOR) has not issued a dedicated regulation specifying the exact formatting or prescriptive content of this internal agreement for R&D credit distribution.1 Consequently, taxpayers must rely on robust internal documentation to support the proportionate tax allocation reported via Schedule K-1-P.1
II. Foundational Framework: Illinois R&D Tax Credit (35 ILCS 5/201(k))
A. Legislative Authority and Extension
The Illinois R&D tax credit incentivizes businesses that invest in qualified research activities within the state.2 Codified under 35 ILCS 5/201(k), the structure of the credit aligns closely with the federal Internal Revenue Code (IRC) § 41 guidelines, focusing on Illinois-sourced innovation in critical sectors such as manufacturing and technology.2
The certainty for long-term tax planning was significantly enhanced by Public Act 103-0595. This legislation confirmed the extension of the R&D tax credit (Credit Code 5340) through tax years ending on or before December 31, 2031.1 This extension, covering a period of seven or more years, underscores the state’s commitment to fostering R&D, thereby heightening the necessity for meticulous, legally sound documentation governing the credit’s use.
B. Credit Calculation Mechanics and Limitation
The Illinois R&D credit is calculated at a rate of 6.5% of incremental Qualified Research Expenses (QREs).2 Incremental QREs are defined as those exceeding a base amount, which is typically the average annual amount of qualifying research expenses incurred during the three taxable years immediately preceding the current tax year.3 Qualified expenses align with federal definitions, including wages for qualified services, costs of supplies, and contract expenses.3
It is important to note that the R&D tax credit is nonrefundable; it can only offset the taxpayer’s Illinois income tax liability (imposed under subsections (a) and (b) of Section 201 of the IITA) down to zero.2 However, the statute permits unused credit amounts to be carried forward for a maximum of five taxable years following the excess credit year.2 The tax credit must be applied to the earliest year for which there is a tax liability.6
C. Eligible Entities and Pass-Through Structure
The credit is available to various entity types, including C corporations, S corporations, and partnerships (including LLCs taxed as partnerships).2 While C corporations claim the credit at the entity level, S corporations and partnerships are classified as pass-through entities (PTEs) that compute the credit at the entity level but must allocate the benefit to their owners. These owners—partners or shareholders—then claim the distributive share of the credit on their respective income tax returns.2
This stable, long-term legislative environment necessitates careful adherence to the rules governing the flow of tax benefits from the PTE to its owners, making the foundational documents—the “Written Agreement”—the cornerstone of compliance for the foreseeable future.
Table 1: Illinois R&D Tax Credit Key Features
| Feature | Detail (Post-2023) | Statutory Reference |
| Credit Rate | 6.5% of Incremental QREs over the base amount | 35 ILCS 5/201(k) |
| Expiration Date | Extended through December 31, 2031 | Public Act 103-0595 1 |
| Refundability | Nonrefundable | 2 |
| Carryforward Period | 5 Taxable Years | 2 |
| Claim Form (PTE Owners) | Schedule 1299-A or 1299-C, supported by Schedule K-1-P | 1 |
III. The Pass-Through Mandate: Allocation under IITA Section 251
A. Statutory Authority for Allocation
The distribution of the R&D credit from a PTE to its owners is governed by IITA Section 251. This section specifically states that partners and shareholders of Subchapter S corporations are entitled to a credit under this Section as provided in Section 251.6 PTEs are generally defined as entities exempt from the tax imposed under subsections (b) or (c) of Section 205 of the IITA.5 Although the PTE itself calculates the credit on its entity return (e.g., Form IL-1065 for partnerships) 7, the actual economic benefit flows directly to the owners to offset their individual or corporate Illinois income tax liabilities.
B. The Requirement for Pro-Rata Distribution
Illinois tax principles generally require that tax credits allocated from a PTE must follow the same proportionate distribution established for income and loss, thereby reflecting the owners’ economic ownership interest in the entity.2 The R&D credit is specifically treated as a distributive share credit.1
A crucial distinction exists between allocation and transfer. The R&D credit is generated by the entity’s activities and is allocated internally to the owners; IDOR guidance explicitly indicates that the R&D credit is not transferable to third parties.1 In contrast, certain other Illinois credits, often those awarded by the Department of Commerce and Economic Opportunity (DCEO), may be transferable.1 Because the R&D credit is non-transferable, the mechanism for distributing it internally must accurately reflect the ownership structure that generated the qualified research expenses (QREs). For S corporations, this requires a strict pro-rata allocation based on stock ownership, as federal law (which Illinois follows) prohibits special allocations of tax items. For partnerships, while flexibility exists under federal Subchapter K, the allocation must ultimately satisfy economic substance tests.
C. The Function of the Written Agreement in Allocation
The “Written Agreement” functions as the definitive legal blueprint that establishes the partners’ or shareholders’ right to claim their distributive share of the tax attributes.1 Because IDOR has not specified a separate, dedicated form for the R&D credit distribution agreement 1, compliance dictates that the entity must rely on its existing, legally binding organizational documents—the Partnership Operating Agreement or the S Corporation Shareholder Agreement—provided these documents contain specific provisions detailing the distribution of all tax attributes, including state tax credits (Code 5340), on a proportionate basis.
The necessity of this document lies in audit defense. Any challenge by IDOR to the credit claimed by an owner via Schedule 1299 will immediately lead to a review of the Schedule K-1-P and, subsequently, the underlying legal agreement to verify that the allocation reported reflects the legal reality of the ownership structure.
Table 2: Allocation vs. Transfer of IL Tax Credits
| Tax Action | IL R&D Credit (Code 5340) | Documentation Required | Statutory Authority |
| Distributive Share (Allocation) | Permitted; mandatory for PTEs. Must be pro-rata based on ownership/economic interest. | Written Agreement (OA/SA) and Schedule K-1-P 1 | IITA Section 251 6 |
| Transfer (Sale to Third Party) | Generally Prohibited/Not Permitted | N/A (Only allowed for specific, DCEO-certified credits) | IDOR Guidance 1 |
IV. Meaning of the “Written Agreement”: Interpreting Compliance
A. Addressing the IDOR Guidance Gap
The analysis confirms a significant interpretive gap: IDOR’s current public guidance, including instructions for Schedule 1299 1, lacks specific regulatory definitions for the internal PTE “Written Agreement” concerning R&D credit allocation. This absence contrasts with IDOR’s explicit requirements for “written agreements” in other areas, such as the Investment Tax Credit (requiring a written agreement with the Department for DCEO-certified projects) 8 or the clear definitions used for sales tax purposes related to software licensing restrictions.10
The absence of a prescribed format for the R&D credit distribution agreement suggests that IDOR defers to the established organizational documents of the PTE, provided they are sufficiently robust and compliant with state and federal allocation principles. This places a heavy administrative burden on taxpayers to ensure their internal documents stand up to scrutiny.
B. The Role of Governing Documents as the “Written Agreement”
For compliance purposes, the organizational document must be viewed as the definitive “Written Agreement” for credit allocation.
- Partnerships and LLCs (Taxed as Partnerships): The Partnership Agreement or LLC Operating Agreement must contain clear, legally binding language concerning the allocation of all tax attributes. This agreement should explicitly detail how state tax credits are shared among partners, ensuring the method is consistent with the general profit and loss sharing ratios.
- S Corporations: The Shareholder Agreement, Articles of Incorporation, or Bylaws collectively constitute the “Written Agreement.” It must be affirmed that S corporations, by federal definition, cannot engage in special allocations; thus, the R&D credit must be allocated strictly in proportion to the shareholders’ stock ownership percentages.
C. The Necessity of Federal Parallels: Risk and Rights (IRC § 41 Nexus)
Given that the Illinois R&D tax credit relies heavily on federal IRC § 41 eligibility standards 2, federal requirements for qualified research expenses (QREs) provide essential context for the “Written Agreement.” Federal law dictates that for contract research expenses to qualify, the taxpayer must bear the financial risk of failure and retain substantial rights to the research results.13
For a PTE, this principle extends to the owners. The “Written Agreement” (Operating or Shareholder Agreement) must demonstrate, through its provisions for capital contributions, distributions, and allocation of losses, that the partners or shareholders effectively bore the economic burden of incurring the QREs that generated the credit. If the allocation scheme within the agreement attempts to shift the credit benefit without shifting the corresponding economic risk—or if it disproportionately allocates the credit to certain members when the capital account maintenance does not support it—the arrangement could be challenged by IDOR auditors as lacking economic substance, despite the K-1-P being technically filed. Proactively incorporating language reflecting the owners’ assumption of financial risk for R&D activities strengthens the validity of the “Written Agreement.”
D. Key Content Requirements for Compliance
To mitigate audit risk resulting from the lack of prescriptive IDOR regulation, the organizational document serving as the “Written Agreement” should contain the following elements:
- Explicit Tax Attribute Allocation: Specific clauses detailing how all tax attributes, including federal and state tax credits (identifying Code 5340 specifically if possible), are allocated to the owners.
- Consistency Rule: Verification that the mechanism for allocating nonrefundable state credits is consistent with the entity’s general allocation of income, loss, and deductions.
- Capital Account Alignment: For partnerships, documentation that the allocation complies with the federal Subchapter K regulations regarding “substantial economic effect” (or in accordance with the partner’s interest in the partnership), linking the economic burden of the R&D activity to the credit benefit received.
V. IDOR Reporting and Compliance Requirements
A. Documenting the Allocation: The Schedule K-1-P
The procedural compliance mechanism relies upon the issuance of Illinois Schedule K-1-P, Partner’s or Shareholder’s Share of Income, Deductions, Credits, and Recapture.1 The PTE prepares and issues this schedule, which details the allocated portion of the R&D credit (Code 5340) to each owner. The calculated R&D credit amount must be entered on the Schedule K-1-P as a distributive share credit.
B. Claiming the Credit at the Owner Level
Owners utilize the information reported on the Schedule K-1-P to claim the credit on their respective Illinois income tax returns.
- Individuals: Claim the distributive share credit on Schedule 1299-C (Income Tax Subtractions and Credits for Individuals).3
- Corporations and Fiduciaries: Claim the credit on Schedule 1299-D.1
- Other Pass-Through Entities (if owned by another PTE): Claim the credit on Schedule 1299-A.1
Regardless of the form, the distributed amount is reported in the section designated for “Distributive Share Credit from K-1-P” (e.g., Column G of Schedule 1299-D).1 If a taxpayer receives multiple Schedules K-1-P listing the R&D credit, the amounts are aggregated and reported as a total distributive share.1
C. Mandatory Attachments and Audit Trail
The critical step in claiming the credit is the supporting documentation. Claimants must ATTACH the Schedule K-1-P received from the PTE to their own tax return (whether individual, corporate, or fiduciary).1 If the Schedule K-1-P is not attached, the credit claimed on the Schedule 1299 series is considered unsupported and subject to immediate disallowance upon review. Furthermore, the tax year ending listed on the Schedule K-1-P received must fall within the owner’s tax year, ensuring the proper chronological application of the credit benefit.1
The mandated audit trail begins with the underlying Qualified Research Expense documentation, flows through the entity’s credit calculation, is legally authorized by the Written Agreement (organizational documents), is reported accurately on the Schedule K-1-P, and concludes with the owner’s successful claim on the appropriate Schedule 1299.
VI. Practical Example: Allocating the R&D Credit in an Illinois Partnership
This example illustrates how an Operating Agreement acts as the “Written Agreement” dictating the proper distribution of the R&D credit.
A. Scenario Setup: Research Tech Partners LLC (RTP)
RTP is an Illinois LLC taxed as a partnership, specializing in manufacturing process innovation. The RTP Operating Agreement (the “Written Agreement”) explicitly states that all items of income, loss, deduction, and state tax credit are allocated pro-rata based on the partners’ defined capital ownership interest.
- Partners: Partner A (60% capital interest), Partner B (40% capital interest).
- Tax Year: Ending December 31, 2024.
B. Calculation of Qualifying Credit (Entity Level)
RTP determines its Illinois R&D credit for 2024:
- Total 2024 QREs incurred in Illinois: $\$500,000$.
- Average 3-Year Base QREs (2021-2023): $\$200,000$.
- Incremental QREs: $\$500,000 – \$200,000 = \$300,000$.
- IL R&D Credit Generated (6.5%): $0.065 \times \$300,000 = \$19,500$.
C. Allocation Details (Governed by Written Agreement)
Since the Operating Agreement (the Written Agreement) dictates a pro-rata allocation based on ownership interest, RTP must distribute the $\$19,500$ credit accordingly:
- Partner A (60%): $\$19,500 \times 0.60 = \$11,700$
- Partner B (40%): $\$19,500 \times 0.40 = \$7,800$
D. Documentation and Claim Process
RTP issues a Schedule K-1-P to Partner A showing a distributed credit of $\$11,700$ and to Partner B showing $\$7,800$. Partner A and Partner B, who are individuals, then attach their respective K-1-Ps to their individual Illinois income tax returns (Form IL-1040), claiming the allocated amount on Schedule 1299-C. The primary assurance of compliance resides in the fact that the allocation reported on the K-1-P directly matches the required allocation percentage established by the legally binding Operating Agreement.
Table 3: R&D Credit Allocation Example (RTP LLC, 2024)
| Partner | Ownership Interest (Per Written Agreement) | Credit Allocation Calculation | Credit Amount Claimed (Via K-1-P) |
| Partner A | 60% | $\$19,500 \times 0.60$ | $\$11,700$ |
| Partner B | 40% | $\$19,500 \times 0.40$ | $\$7,800$ |
| Total | 100% | Total Entity Credit Generated | $19,500 |
The consistent application of the agreement ensures that if either partner is audited, the documentation—flowing from the K-1-P back to the Operating Agreement—provides the legally defensible basis for the credit claimed.
VII. Conclusion and Recommendations for Compliance Strategy
The meaning of the “Written Agreement” in the context of the Illinois R&D tax credit allocation post-2023 is found not in a specific IDOR-mandated form, but within the existing Partnership Operating Agreement or S Corporation Shareholder Agreement of the pass-through entity. The core function of this agreement is to legally bind the entity to distribute the nonrefundable R&D credit (Code 5340) pro-rata to its owners, consistent with IITA Section 251. The state’s reliance on the consistency between the PTE’s foundational documents and the tax reporting on Schedule K-1-P places the responsibility for compliance squarely on meticulous internal governance.
Actionable Recommendations for Taxpayers
To ensure the integrity of the R&D credit allocation and defend against potential challenges, entities should adopt the following compliance strategies:
- Immediate Review of Governing Documents: Tax professionals must promptly review all existing organizational agreements (Operating Agreements, Shareholder Agreements) to ensure they contain specific language addressing the allocation of state tax credits, including the R&D credit. Generic clauses referencing only “income and loss” may be insufficient to fully document the entitlement to state-specific tax attributes.
- Verify Economic Consistency: For partnerships, the allocation scheme outlined in the Written Agreement must align with the economic substance principles derived from federal tax law. This involves ensuring that the partners claiming the credit are demonstrably the parties bearing the financial risk associated with the Qualified Research Expenses.
- Strict Adherence to S Corp Rules: S Corporations must rigorously ensure that the allocation of the R&D credit adheres strictly to the shareholder’s proportional stock ownership, as any attempt at a special allocation would invalidate the compliance mechanism.
- Maintain a Rigorous Audit Trail: Beyond the Written Agreement, maintaining a complete, traceable audit file linking the QRE expenditures, the entity’s calculation, and the final Schedule K-1-P issuance is mandatory.1 The Schedule K-1-P must be securely attached to the owner’s annual Illinois tax return to validate the claim.
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state










